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Zumbrunn Wojczyńska A, Hovijitra RS
and Ettlin DA (2020) The
Pain–to–Well-Being Relationship in
Patients Experiencing Chronic
Orofacial Pain.
Front. Neurol. 11:557415.
doi: 10.3389/fneur.2020.557415
The Pain–to–Well-Being Relationship
in Patients Experiencing Chronic
Orofacial Pain
Kanokporn Bhalang 1*, Beat Steiger 2, Nenad Lukic 3, Aleksandra Zumbrunn Wojczyńska 3,
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Introduction: Orofacial pain features may negatively influence a person’s well-being
and vice versa. Some aspects of well-being can be measured with axis II instruments
that assess patients’ psychosocial and behavioral status. The aim of this study was to
investigate associations between pain features and psychosocial variables as indicators
of well-being.
Materials and Methods: Seven hundred ninety-nine anonymized datasets collected
using the Web-based Interdisciplinary Symptom Evaluation (WISE) of patients reporting
to the Interdisciplinary Orofacial Pain Unit, University of Zurich, between March 19, 2017
and May 19, 2019, were analyzed. Pain features including intensity, number of locations,
impact, and duration were evaluated. Psychometric measures assessed pain-related
catastrophizing and disability, illness perception, distress, anxiety, depression, injustice
experience, dysmorphic concerns, and insomnia.
Results: Most patients were between 30 and 59 years old (58.3%), female (69.8%),
working (66.0%), and experienced pain for more than 6 months (68.5%). Pain intensities
were higher in women than men and higher in disabled than working patients. Scores
indicating elevated stress and depression were also observed in disabled patients.
The sample prevalence rates of clinically relevant axis II instrument scores were as
follows: Graded Chronic Pain Scale for the Head (GCPS-H), 27%; Patient Health
Questionnaire 4 (PHQ4), 21%; PHQ9, 21%; Pain Catastrophizing Scale (PCS), 20%;
General Anxiety Disorder 7 (GAD7), 15%; Insomnia Severity Index (ISI), 15%; Injustice
Experience Questionnaire (IEQ), 14%; GCPS for the Body (GCPS-B), 13%; PHQ for
Stress (PHQstr), 6%; and Dysmorphic Concern Questionnaire (DCQ), 2%. Noteworthy
results of correlation analysis of the clinically relevant axis II scores and pain measures
were as follows: the PHQstr had moderate associations (0.34–0.43) with the sum
of pain intensity at rest and during function, number of pain locations, and typical
pain intensity. The IEQ scores were moderately associated with typical pain intensity
at 0.39. The DCQ scores were moderately associated with pain extension at 0.41.
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Conclusions: Moderate correlations of certain pain and well-being measures were
found in patients reporting clinically relevant stress, injustice experience, and dysmorphic
concern, all of which reflect impaired well-being. PHQ4 is suitable for routine distress
screening in the clinical setting.
Keywords: injustice, stress, well-being, orofacial pain, dysmorphic
INTRODUCTION
Pain is a complex, multidimensional construct that includes
features such as intensity (at rest and during movements),
spread, symmetry, chronicity, and impact of pain. Analogous to
pain in any other body region, orofacial pain (OFP) negatively
influences well-being and vice versa (1). Well-being can be
conceptualized as a spectrum, with happiness, minimal distress,
and high well-being at one end and elevated depression, anxiety,
and low well-being at the other (2). Diverse psychometric
instruments exist for indirectly measuring well-being, e.g., the
Hospital Depression and Anxiety Scale, the General Health
Questionnaire, the Perceived Stress Scale, and the Positive and
Negative Affect Schedule (3). Accordingly, a well-being proxy
measure may consist of a diverse set of psychometric instruments
that offer information on a patient’s psychological and behavioral
status. From a pain management perspective, well-being proxy
measures, such as anxiety, depression, catastrophizing, and
others, are all relevant in influencing treatment outcomes in
patients experiencing OFP and temporomandibular disorders
(TMDs) (4–7). Another important negative influence on well-
being is unemployment, resulting in feelings of worry, insecurity,
and stress due to changes in the patient’s financial situation (8, 9).
Pain and well-being are interrelated. Hence, a dual-axis
diagnostic system has been proposed for evaluating patients
experiencing OFP and TMD (10). This system differentiates
physical diagnoses (which can be grouped into axis I) from
the patients’ psychosocial and behavioral status (known as axis
II) reflecting their well-being. Notably, axis I diagnoses are
categorical in nature, such as temporomandibular joint disc
displacement or arthritis, while axis II construct measures have
ordinal values. According to an international expert panel, axis
II instruments aim at assessing the psychosocial and behavioral
status (including pain-related disability) (11). For the purpose
of this paper, we refer to pain as a symptom and not as a
diagnosis or psychological status per se. Sleep has been proposed
as an additional axis II construct because a strong relationship
between self-assessed sleep disturbances, OFP, and TMDhas been
observed (12, 13). Perceived injustice, anger, illness perception,
catastrophization, and dysmorphophobia are additional potential
moderators of the pain–to–well-being relationship (14–17).
The Web-based Interdisciplinary Symptom Evaluation
(WISE) is an online tool based on self-reports that assists
clinicians in the comprehensive assessment of patients with
OFP or TMD (18). WISE records sex, age, and employment
status. This evaluation further combines a description of pain
features with widely available in-depth psychometric measures.
The automatically generated summary report supports clinicians
in identifying case complexity and disability levels. WISE thus
facilitates resource planning for the initial consultation, such
as allocation of time and appropriate healthcare specialists.
Anonymized WISE data can be extracted for research purposes.
Using anonymous data collected by the WISE tool, the aim
of this study was to correlate pain features with other axis II
construct measures reflecting well-being in patients experiencing
OFP of mixed etiologies. Further, we analyzed whether known
confounders such as sex, age, employment status, and pain
duration influenced psychometric scores and pain features.
MATERIALS AND METHODS
Subjects
This study included 799 anonymized WISE datasets of patients
reporting to the Interdisciplinary Orofacial Pain Unit, Center
of Dental Medicine, University of Zurich, Switzerland, between
March 19, 2017 and May 19, 2019. The spectrum of axis I
diagnoses encountered in this unit has been reported elsewhere
(16). Patients completed the WISE questionnaire prior to their
first clinical appointment. Anonymized data were retrieved
from a server located at Hof University of Applied Science,
Germany, and exported in csv format for statistical analysis.
According to Swiss law, researchers can use strictly anonymized
data and do not require approval by an ethics committee.
Only fully completed WISE datasets of patients reporting OFP
were analyzed, given that the subjects consented to the use of
their anonymized data for research. Data related to non-painful
symptom reports were excluded.
Web-Based Interdisciplinary Symptom
Evaluation Datasets
The WISE system is a Web-based instrument for
interdisciplinary subject-tailored symptom evaluation in patients
experiencing OFP and TMD (18). WISE combines a symptom-
oriented checklist with validated in-depth questionnaires, also
referred to as case finding instruments. The questionnaires are
presented when the checklist scores exceed threshold values
and thus indicate a burden related to the screening item.
Graphical maps offer patients the opportunity to indicate their
pain location, intensity, and duration in various defined oral
and cranial tissues as well as other body regions. In addition
to pain measures, several other psychometric instruments are
integrated. Only German and English versions of the WISE
were completed. German versions of the applied measures are
available. The following variables from the WISE datasets were
used in this study.
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FIGURE 1 | Example of a pain diagram with marked pain locations. The most intense red hue signifies the highest pain intensity in the sternocleidomastoid muscle.
The broadest green border reflects the highest pain intensity upon jaw movement in the masseter area.
Pain Features
Pain features were captured by detailed interactive pain maps
of the head and neck and front/back view maps of the rest
of the body. Pain locations were differentiated by 93 selectable
anatomical areas across the entire body and 72 areas across
the head and neck region (Figure 1). Patients marked painful
areas by clicking on a defined area and reported the typical pain
intensity at rest and upon movement. Both were reported for the
last 4 weeks on an 11-point numeric rating scale (NRS) for pain.
Different pain intensities at rest were represented by gradients of
red, and different pain intensities upon movement were captured
by graded widths of anatomical green borders.
Using the same NRS, typical (PI-typ) and maximum (PI-
max) pain intensities of the chief complaint were additionally
reported. Pain extension for the body (P-ext-B) was defined as
the total number of pain locations across the entire body and
pain extension for the head (P-ext-H) was defined as the number
of pain locations across the head and neck region (left part of
Figure 1). Pain impact at rest and pain impact upon movement
were calculated as the sum scores of pain intensities across the
head and neck region at rest (
∑
-PI-rest-H) and upon movement
(
∑
-PI-move-H), respectively. The duration of OFP (P-dur) as a
measure of chronicity was grouped by intervals: <3 months, 3–6
months, 6 months−2 years, 2–5 years, >5 years.
Axis II Psychometric Measures
Brief Illness Perception Questionnaire
The Brief Illness Perception Questionnaire (B-IPQ) (19–21)
assesses cognitive and emotional representations of illness and
health threat. Eight questions covering different aspects of illness
perception were rated on an NRS ranging from 0 to 10. The
maximum score is 80. No cutoff score has been reported for this
questionnaire. Test–retest reliability of the single items of the
B-IPQ ranged from 0.48 to 0.70; a coefficient alpha value was
not reported.
Dysmorphic Concern Questionnaire
TheDysmorphic Concern Questionnaire (DCQ) (22, 23) assesses
excessive preoccupation with an imagined or a real minimal
defect in appearance that is associated with a significant impact
on psychosocial functioning. The questionnaire consists of seven
items that cover different aspects of dysmorphic concern. Each
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item is rated on an ordinal scale ranging from 0 to 3, resulting
in a maximum sum score of 21. A cutoff score of nine indicates
a possible body dysmorphic disorder. The following coefficient
alpha for the DCQ has been reported: 0.85; test–retest reliability
was not reported.
Graded Chronic Pain Scale Version 2.0 for the Head or for
the Body
The Graded Chronic Pain Scale (GCPS) (24) consists of three
pain intensity scales ranging from “no pain” (=0) to “pain as
bad as it could be” (=10) assessing current, worst, and average
pain intensity for the last 30 days. The disability days report
the number of days being kept from daily activities by pain for
the last 3 months. The number of days determines a disability
score ranging from 0 to 3. Three additional scales measure the
interference by pain during (1) daily activities, (2) recreational,
social, and family activities, and (3) working ability on a scale
from “no interference” (=0) to “unable to carry on any activities”
(=10) for the last 30 days. The average value of these three
disability scales yields a disability score ranging from 0 to 3.
Combining the pain activity interference score with the disability
day score results in a disability sum score ranging from 0 to 6.
Two separate disability scores due to pain in the head (GCPS-H)
or the body (GCPS-B) were calculated. Scores ≥3 are considered
as high disability and severely limiting. The following coefficient
alpha has been reported: 0.71 for TMD pain; test–retest reliability
has not been reported.
General Anxiety Disorder 7
The General Anxiety Disorder 7 (GAD7) (25) assesses general
anxiety in primary care patients. Seven items cover different
aspects of general anxiety. For the question “Over the last 2 weeks,
how often have you been bothered by the following problems?
“items are scored on a four-point scale from not at all” (=0),
“several days” (=1), “half of the days” (=2), and “nearly every
day” (=3). Summary scores range from 0 to 21 and indicate
anxiety levels of “none/minimal” (0–4), “mild” (5–9), “moderate”
(10–14), or “severe” (>14). The following coefficient alpha has
been reported: 0.92; for test–retest reliability: 0.83.
Injustice Experience Questionnaire
The Injustice Experience Questionnaire (IEQ) (26–28) assesses
injustice experienced due to accidents, injuries, or maltreatment.
Twelve items reflect the frequency of thoughts, beliefs, and
emotions associated with injury. They are rated on a scale
with the following response options: “never” (=0), “rarely”
(=1), “sometimes” (=2), “often” (=3), to “all the time” (=4).
The maximum score is 48. Scores ≥18 indicate the need for
professional evaluation. The following coefficient alpha has been
reported: 0.92; for test–retest reliability: 0.90.
Insomnia Severity Index
The Insomnia Severity Index (ISI) (29, 30) screens for sleep
disorders by measuring the severity of insomnia problems,
sleep-related satisfaction, and interference on a scale of “none”
(=0), “mild” (=1), “moderate” (=2), “severe” (=3), and “very
severe” (=4) for the items falling asleep, staying asleep, and
waking up too early over the past 2 weeks. On a scale from
“very satisfied” (=0), “satisfied” (=1), “moderately satisfied”
(=2), “dissatisfied” (=3), to “very dissatisfied” (=4), the patient
indicates how satisfied/dissatisfied he/she perceives his/her
current sleep pattern. On three additional scales from “not at all”
(=0), “a little” (=1), “somewhat” (=2), “much” (=3), to “very
much” (=4), the patient is asked how much he/she considers
his/her sleep problem to interfere with daily activities, how
noticeable the interference by his/her sleep problem is to others,
and how worried/distressed the patient is because of his/her
sleep problem. The maximum score is 28, with scales of “none”
(0–7), “subthreshold” (8–14), “moderate” (15–21), or “severe”
(>21). The following coefficient alpha has been reported: 0.74;
test–retest reliability was not reported.
Pain Catastrophizing Scale
The Pain Catastrophizing Scale (PCS) (31, 32) assesses
catastrophizing thoughts and corresponding behavior. The
questionnaire has 13 items that are scored on a five-point ordinal
scale [“not at all” (=0), “to a slight degree” (=1), “to a moderate
degree” (=2), “to a great degree” (=3), or “all the time” (=4)].
Scores can also be calculated for three subscales of helplessness,
maximizing, and ruminating. The maximum value is 52 for the
entire questionnaire. The corresponding cutoff values are 13
for helplessness, five for maximizing, 13 for ruminating, and
30 for the entire questionnaire. These cutoff values correspond
to the 75th percentile. The following coefficient alpha has been
reported: 0.87; for test–retest reliability: 0.75.
Patient Health Questionnaire 4
The Patient Health Questionnaire 4 (PHQ4) (33) screens for
anxiety and depression. This questionnaire consists of two
subscales, GAD2 (items one and two of the GAD7) and PHQ2
(items one and two of the PHQ9). Items are scored on an ordinal
scale ranging from 0 to 3 using the same labels as the GAD7.
Scores can be calculated for the two subscales (maximum score
= 6) and overall (maximum score = 12). Scores ≥6 for the
total score and three for the sub-scores indicate expert evaluation
referral. The following coefficient alpha has been reported: 0.87;
for test–retest reliability: 0.81.
Patient Health Questionnaire 9
The PHQ9 (34, 35) assesses the severity of depression. Nine
items covering different aspects of depression are scored on an
ordinal scale ranging from 0 to 3 using the same labels as the
GAD7. Summary scores range from 0 to 27, indicating depression
levels of “none/minimal” (0–4), “mild” (5–9), “moderate” (10–
14), “moderately severe” (15–19), or “severe” (>19). A cutoff
score range of 8–11 has been recommended for expert evaluation
referral. The following coefficient alpha has been reported: 0.89;
for test–retest reliability: 0.84.
Patient Health Questionnaire for Stress
The Patient Health Questionnaire for Stress (PHQstr) (34,
36) is a 10-item subscale of the Primary Care Evaluation of
Mental Disorders (PRIME-MD) Patient Health Questionnaire
that addresses psychosocial stress burden. Items are scored on
an ordinal scale ranging from “not at all” (=0), “a little” (=1),
Frontiers in Neurology | www.frontiersin.org 4 December 2020 | Volume 11 | Article 557415
Bhalang et al. Orofacial Pain and Well-Being
T
A
B
L
E
1
|
S
a
m
p
le
c
h
a
ra
c
te
ris
tic
s
(N
=
7
9
9
).
G
e
n
d
e
r
A
g
e
g
ro
u
p
E
m
p
lo
y
m
e
n
t
s
ta
tu
s
P
a
in
d
u
ra
ti
o
n
F
M
1
0
–1
9
2
0
–2
9
3
0
–3
9
4
0
–4
9
5
0
–5
9
6
0
–6
9
≥
7
0
T
ra
in
in
g
W
o
rk
in
g
R
e
ti
re
d
D
is
a
b
le
d
N
o
jo
b
<
3
m
o
n
th
s
3
–6
m
o
n
th
s
6
m
o
n
th
s
−
2
y
e
a
rs
2
–5
y
e
a
rs
>
5
y
e
a
rs
5
5
8
2
4
1
5
3
1
2
2
1
4
8
1
6
2
1
5
6
9
2
6
6
8
0
5
2
7
1
1
3
5
2
2
7
1
2
4
1
2
8
2
4
8
1
4
9
1
5
0
6
9
.8
%
3
0
.2
%
6
.6
%
1
5
.3
%
1
8
.5
%
2
0
.3
%
1
9
.5
%
1
1
.5
%
8
.2
%
1
0
.0
%
6
6
.0
%
1
4
.1
%
6
.5
%
3
.4
%
1
5
.5
%
1
6
.0
%
3
1
.0
%
1
8
.6
%
1
8
.8
%
TABLE 2 | Descriptive statistics of pain measures used in the study (N = 799).
Pain measures Maximum
possible score
Mean SD
Number of pain locations across the entire body
(P-ext-B)
93 8.69 9.56
Number of pain locations across the head and neck
region (P-ext-H)
72 5.54 6.91
Typical pain intensity (PI-typ) 10 4.91 2.44
Maximum pain intensity (PI-max) 10 7.10 2.49
Pain intensity sum score at rest across the head and
neck region (
∑
PI-rest-H)
720 33.4 48.7
Pain intensity sum score upon movement across the
head and neck region (
∑
PI-move-H)
720 38.2 51.3
to “a lot” (=2). Summary scores range from 0 to 20 indicating
the degree of psychosocial stress burden by the following levels:
“none/minimal” (0–4), “mild” (5–9), “medium” (10–14), or
“severe” (>14). No coefficient alpha nor test–retest reliability
was reported.
Statistical Analysis
The data were analyzed using SPSS (Version 22, Armonk,
New York). Descriptive statistics were used to characterize the
datasets. Spearman rank correlation was used for correlation
analysis. To determine the effect size, small (0.1 < r <
0.3), moderate (0.3 < r <0.5), and strong (r ≥ 0.5) were
used for the different association levels (37). Analysis of
variance was used with a Bonferroni or Tamhane correction
for post hoc testing depending on whether the variances were
equal or not. A significance level of ≤0.05 was considered
statistically significant.
RESULTS
Most patients were female (N = 558; 69.8%), with a female-
to-male ratio of 2.3:1. Among the patients, 73.6% (N =
588) were 20–59 years old, 66.0% were working (N = 527),
and 84.4% suffered from pain for more than 3 months
(N = 675) (Table 1).
The descriptive statistics of various pain measures are shown
in Table 2. On average, patients had 8.69 pain sites across
the entire body and 5.54 pain sites across the head region.
The mean typical pain intensity was 4.91, and the mean
maximum pain intensity was 7.10. With an average of 33.4,
the intensity sum score at rest was lower compared with upon
movement (38.2).
We determined the influence of patient characteristics (sex,
age, employment status, and pain duration) on the mean of
the assessed pain features. Sex had a significant influence
on PI-typ, PI-max (Figure 2), and
∑
-PI-rest-H, with women
reporting higher mean values. Effects of age were found for P-
ext; patients aged 30–39 years indicated more pain locations
compared with older patients (>60 years old). Employment
status demonstrated significant effects on all pain-related
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measures. Disabled patients significantly indicated more pain
locations compared to employed patients, patients in training, or
retired patients. Working patients presented more pain locations
compared to retired patients. The highest typical and maximum
pain intensities were reported by patients without a job and by
disabled patients (Figure 2). The
∑
-PI-rest-H was highest in
disabled patients. Pain duration had significant effects on all pain-
related measures, except for PI-typ and PI-max. The number of
pain locations,
∑
-PI-rest-H, and
∑
-PI-move-H increased with
the duration of pain.
The number of patients who completed one of the case
finding questionnaires ranged from 216 (GAD7) to 799 (PCS,
PHQ4, and PHQstr). The percentage of patients reaching a
clinically relevant score (cutoff) ranged from 5.1% (DCQ) to
73.7% (PHQ9) (Table 3).
The analysis of variance of the selected mean axis II domain
scores grouped by selected patient characteristics (age group
and employment status) is shown in Figure 3. There were no
significant effects of age on axis II measures, except that older
patients (>60 years) had lower PHQstr scores than those aged
30–59 years, and patients in the middle age groups had a higher
PHQ4 score than those in the younger age groups and in older
patients. Employment status had a significant effect on several
measures. GCPS-H scores were higher among disabled patients
or patients with no job than among trainees, working, or retired
patients; GCPS-B scores were higher in disabled patients than
in trainees, working, or retired patients. PCS and PHQ4 values
were higher in disabled patients or patients with no job compared
with trainees, working, or retired patients. PHQ9 scores were
higher in disabled than in retired or working patients, and
PHQstr scores were higher in disabled patients than in trainees,
working, or retired patients. Pain duration had no significant
effect on psychosocial variables except for PHQ4 and PHQstr,
where patients experiencing pain longer than 5 years had higher
mean values compared with patients with a pain duration of
<3 months.
For the correlations between various pain features and axis II
measures (Figure 4A), the following five pain features showed
moderate correlation effects (r ≥ 0.30; P < 0.50) with other
axis II measures: (1)
∑
-PI-rest-H with PCS, PHQ4, PHQstr,
GAD7, IPQ, GCPS-H, andGCPS-B; (2)
∑
-PI-move-Hwith PCS,
PHQ4, GCPS-H, and GCPS-B; (3) PI-max with PCS, IPQ, and
GCPS-H; (4) PI-typ with PCS and GCPS-H; and (5) P-ext-B
with PHQ4 and PHQstr. Pain duration showed only weak or no
correlations with all pain measures. All other axis II measures
(IEQ, ISI, and DCQ) only had weak or no correlations with
pain features.
From Figure 4B, when correlation analyses were performed
after dichotomizing questionnaire scores into above and below
cutoff values, we found that PHQstr scores above nine (N =
46) significantly correlated with levels of P-ext, PI-typ,
∑
-PI-
rest-H, and
∑
-PI-move-H (r = 0.34–0.47; P < 0.05). GCPS-B
scores above cutoff level (N = 107) significantly correlated with
P-ext-B and
∑
-PI-move-H (r = 0.30 and 0.31, respectively; P
< 0.001). DCQ scores above cutoff level (N = 22) moderately
correlated (r = 0.32–0.41) with P-ext, PI-max,
∑
-PI-rest-H,
and
∑
-PI-move-H. IEQ scores above cutoff level (N = 93)
significantly correlated with PI-typ (r = 0.39; P < 0.001). ISI
scores above 14 (N = 121) significantly correlated with PI-typ
(r = 0.31; P < 0.001).
DISCUSSION
The aim of this study was to further understand the pain–
to–well-being relationship in patients experiencing OFP. Thus,
the relationships between various pain features and other
psychometric measures as indicators of well-being were analyzed.
Furthermore, pain features and psychometric scores were
analyzed with regard to patient characteristics, such as gender,
age group, employment status, and pain duration.
Data Origin and Sample Characteristics
Anonymized data were derived from a large clinical cohort
of 799 patients who completed the WISE between March 19,
2017 and May 19, 2019. This comprehensive evaluation tool
is routinely used in the Orofacial Pain Unit of the Center of
Dental Medicine, University of Zurich, to plan the resources
for the initial consultation, such as allocation of time and
appropriate healthcare specialists. Table 1 indicates that the
gender proportion and age distribution matched those reported
in other studies on patients seeking care for OFP (16, 38–40).
Three quarters of our sample were in training or working, while
6.5% of patients were disabled. Most patients were considered
chronic pain sufferers since more than 80% of them experienced
pain longer than 3 months (41).
Pain Scores and Relation to Patient
Characteristics
On average, patients reported pain in ∼9 of possible 93
locations as defined in the diagrams in Figure 1, indicating
that the majority experienced locoregional pain. On the 11-
point numerical pain scale, the reported mean pain intensity
was moderate (4.9), with a mean maximum intensity of 7.1. As
expected, pain was more intense upon movement compared to
at rest (Table 2). Pain intensities were higher in women than
men and higher in disabled than working patients (Figure 2).
As was previously reported, pain is generally more prevalent
in females in the head and neck areas (42, 43). Somewhat
counterintuitively, pain extension decreased from middle to old
age as was reported in fibromyalgia patients (44). This may
be due to the observation that OFP origins shift across age
from myogenic to neurogenic (e.g., trigeminal neuralgia) and
the latter being typically a localized pain (45, 46). This may
also explain why working subjects indicated more pain locations
than those retired. Recent findings do not indicate that OFP
mediates the relationship between socioeconomic inequalities
(linked to disability) and the impacts of oral conditions on daily
life (47).
Well-Being Scores
Table 3 summarizes the axis II questionnaire scores serving as
proxies for well-being. The PHQ4 is part of the WISE checklist
and was therefore completed by all patients. All patients were also
asked to complete the PCS due to relevant associations of pain
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FIGURE 2 | Analysis of variance between selected patient characteristics (sex, employment status) and selected pain features (P-ext-H, number of pain locations
across the head and neck region; PI-typ, typical pain intensity; PI-max, maximum pain intensity); Post hoc tests with Bonferroni correction or Tamhane correction (*P
≤ 0.05 **P ≤ 0.01 ***P ≤ 0.001).
catastrophizing with pain-related disability, number of painful
body sites, and pain-related impact (7). The sample prevalence
rates of clinically relevant axis II instrument scores (above cutoff)
in descending order were as follows: GCPS-H, 27%; PHQ4 and
PHQ9, 21%; PCS, 20%; GAD7, 15%; ISI, 15%; IEQ, 14%; GCPS-B,
13%; PHQstr, 6%; and DC, 3%. No cutoff value has been reported
for the IPQ. The GCPS can predict the healthcare utilization
cost for chronic OFP patients (48). Approximately one in four
patients experienced moderate or severe impairment due to
craniofacial pain (and 13% due to bodily pain). Almost as many
had PHQ scores that warrant further evaluation for depression,
whereas 15% experienced symptoms characteristic of a GAD.
The 20% of patients reporting pain catastrophizing scores above
29 might have an elevated risk of delayed pain recovery (49).
Pain catastrophizing was demonstrated to mediate the effects of
distress in OFP patients, which was attributed to the helplessness
component of the PCS (50). Due to the sample overlap, the
prevalence of moderate and severe grades of insomnia (15%)
confirms the 16% we previously reported (13). A novel finding
of this study is that approximately one in seven patients (14%)
perceived injustice of a clinically relevant level. It is noteworthy
that patients concerned about injustices in the treatment they
receive are vulnerable to greater emotional distress, prolonged
work disability, invalidating or stigmatizing reactions of others,
and poor pain-related outcomes (51–53). According to Sullivan
(54), blame cognitions may have an impact on feelings of
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TABLE 3 | Scores of the axis II psychometric measures [Note that ≥ cutoff score (CO) indicates clinical relevance].
Domains (alphabetical order) N Max Mean SD ≥ cut-off score CO
CO N % domain % of study sample
Dysmorphic Concern Questionnaire (DCQ) 432 21/21 1.45 3.35 9 22 5.10 3
General Anxiety Disorder 7 (GAD7) 216 21/21 10.8 3.81 10 120 55.6 15
Graded Chronic Pain Scale-Head (GCPS-H) 688 6 1.79 0.84 3 218 31.7 27
Graded Chronic Pain Scale-Body (GCPS-B) 576 6 1.04 1.62 3 107 18.5 13
Illness Perception Questionnaire (IPQ) 566 78/80 44.5 11.5
Injustice Experience Questionnaire (IEQ) 302 48/48 14.1 11.3 18 108 35.8 14
Insomnia Severity Index (ISI) 296 28/28 13.5 5.58 15 121 40.9 15
Pain Catastrophizing Scale (PCS) 799 51/52 16.6 12.6 30 157 19.6 20
Patient Health Questionnaire 4 (PHQ4) 799 12/12 3.13 3.10 6 165 21.0 21
Patient Health Questionnaire 9 (PHQ9) 232 25/27 12.5 4.81 10 171 73.7 21
Patient Health Questionnaire Stress (PHQstr) 799 20/20 6.24 3.74 10 46 18.9 6
FIGURE 3 | Analysis of variance between selected patient characteristics (age group, employment status) and selected axis II measures [Patient Health Questionnaire
4 (PHQ4), Patient Health Questionnaire Stress (PHQstr), General Anxiety Disorder 7 (GAD7), Graded Chronic Pain Scale-Head (GCPS-H), Graded Chronic Pain
Scale-Body (GCPS-B), Pain Catastrophizing Scale (PCS), Patient Health Questionnaire 9 (PHQ9)]; Post hoc tests with Bonferroni correction or Tamhane correction (*P
≤ 0.05 **P ≤ 0.01 ***P ≤ 0.001). Maximum scores are listed in Table 3. Black bars indicated cutoff scores of the respective psychometric instrument.
anger and revenge motives that warrant interventions to alter
the individual’s perceptions of the offender. Although perceived
stress has been reported to predict the incidence of painful TMDs,
the number of patients (6%) reportingmedium to severe stress on
the PHQstr was rather low in this sample, likely due to the broad
variety of pain origins (16, 18, 29). And only 2% reached clinically
relevant DCQ scores. Health anxiety questionnaire was reported
to have good association with OFP and other related syndromes
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FIGURE 4 | Correlations between scores of pain measures and scores of axis
II measures as proxies for well-being [Pain measures number of pain locations
across the entire body (P-ext-B), number of pain locations across the head
and neck region (P-ext-H), summary score of pain intensity at rest across the
head and neck region (
∑
-PI-res-H), summary score of pain intensity upon
movement across the head and neck region (
∑
-PI-move-H), maximum pain
intensity (PI-max), typical pain intensity (PI-typ), and pain duration (P-dur) and
axis II measures Graded Chronic Pain Scale-Head (GCPS-H), Graded Chronic
Pain Scale-Body (GCPS-B), Pain Catastrophizing Scale (PCS), Patient Health
Questionnaire 4 (PHQ4), Patient Health Questionnaire 9 (PHQ9), General
Anxiety Disorder 7 (GAD7), Patient Health Questionnaire Stress (PHQstr),
Illness Perception Questionnaire (IPQ), Injustice Experience Questionnaire
(IEQ), Dysmorphic Concern Questionnaire (DCQ), and Insomnia Severity Index
(ISI); Spearman rank correlation was used for the analysis (P = 0.05), and
darker blue shades represent higher correlations]. (A) Correlations between
scores of pain measures and all scores of axis II measures. (B) Correlations
between scores of pain measures and scores above clinical relevance of axis
II measures.
(55) and was found to be a strong predictor of chronic OFP (56).
However, we only observed moderate correlation between GAD7
score and
∑
-PI-rest-H in our subjects. The inclusion of patients
experiencing various types of disorders in this study is justified by
the pain associations with axis II psychological and psychosocial
variables independent of pain origin (57).
Well-Being Scores in Relation to Patient
Characteristics
Women not only experienced significantly more intense pain
than men (Figure 2) but also suffered significantly severer
impairment (data not shown). A multitude of mechanisms
has been proposed to explain sex differences in pain and
emotional processing, including the effects of sex hormones,
differences in endogenous opioid function, cognitive/affective
influences, coping patterns, and contributions of social factors
such as stereotypic gender roles (58, 59). In our sample, PHQ4
and PHQstr scores were highest in 50–59-year-old subjects,
which is consistent with a Japanese study reporting PHQ
scores being low in young adulthood, increasing in middle
age (peaking during age 50–59), and then decreasing again
in older age (60). The relationship between employment-
related factors and chronic pain lacks adequate research (61).
Our findings that being disabled and/or unemployed was
negatively associated with various axis II instrument scores
emphasize the need for routine collection of information
on employment status to optimize clinical care and future
research (62). It is noteworthy that daily activities are negatively
influenced not only by pain itself but also by pain-related
fear (63).
Correlations Between Pain and Well-Being
Scores
As the structure of the WISE instrument is modular, not all 799
patients completed each axis II instrument or each pain-related
questionnaire. However, everyone was requested to complete
questions related to pain locations, intensities, and duration.
None of the calculated correlations was strong (r ≥ 0.5). The
fact that the PCS, PHQ4, and PHQstr were completed by all
patients and the GCPS-H by nearly 90% of them largely explains
their highest correlation levels with pain intensity variables and
pain extension for the entire sample (Figure 4A). Such effects
reversed when only cases with clinically relevant scores (above
cutoff) were analyzed (Figure 4B). Our data thus support the
routine use of PHQ4 as a screener for anxiety and depression
in the clinical setting, as recommended by international
expert panels (11). PEG, a three-item scale measuring pain
intensity (P), interference with enjoyment of life (E), and
interference with general activity (G), is another tool available for
initial pain patient evaluation (64). Psychological comorbidity
has been shown to influence patients’ illness perceptions
by means of pain ratings, treatment-seeking behavior,
and treatment adherence, as well as recovery after surgical
procedures (65–67).
The well-being of patients is more likely compromised when
we defined compromised well-being by axis II scores at or
above cutoff values. Figure 4B reveals that patients experiencing
widespread pain and high sum intensity scores suffered high
distress levels (PHQstr scores ≥10; N = 46; r = 0.34–0.47;
all P-values <0.05). This confirms previous findings that self-
reported stress independent of its origin (pain or non-pain-
related) can initiate or exacerbate the impact of TMDs, chronic
pain, and disability (68, 69). However, further research is
needed to clarify the amount, timing, severity, and type of
stress that is needed to contribute, maintain, and exacerbate
persistent pain (70). While stress is often comorbid with anxiety,
depression, as well as pain catastrophizing and persistence,
clinically relevant scores of these domains did not significantly
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correlate with any pain measure in our study (6, 71–73). The
low number of patients experiencing dysmorphic features (DCQ
scores ≥9; N = 22) makes it difficult to interpret correlations
with pain features. Still, this may be an interesting topic for
further exploration.
A new and highly significant finding was that typical pain
intensity moderately correlated with high scores on the IEQ
(scores >17; N = 93). The IEQ has proven to be a good
predictor for delayed healing in patients experiencing pain and
post-traumatic stress (6, 74, 75). However, we are unaware
of the use of this questionnaire in the OFP domain, except
for its German-language validation (28). Notably, patients
perceiving injustice also had pain for a longer duration
compared to subjects with lower IEQ scores (r = 0.27;
P < 0.001).
Although patients with OFP report sleep disturbances
disproportionately more often compared with the general
population (13), clinically relevant insomnia only associated
with typical pain intensity at a moderate level, which is
in line with previous observations (ISI scores >15; N =
121) (76). This finding indicates that other psychosocial
variables likely contribute more to insomnia than the
selected pain features, and it supports the notion that
sleep impairment is more likely a predictor of OFP than
pain is of sleep impairment (77). Surprisingly to us, pain
duration did not correlate with any of the axis II measures
employed in our study, except for a weak correlation with
perceived injustice.
A key difference of this study as compared to the OPPERA
studies (78) is that our sample is a pure clinical sample and
therefore more likely represents a clinical population that most
dentists encounter in their practices. Taken together, our results
support Schiffman et al. (11) for the use of GCPS and PHQ4 as
screening tools in clinical practice; however, for comprehensive
assessments of orofacial patients’ well-being, not only PHQ9
and GAD7 but also PHQstr, DCQ, IEQ, and ISI should be
utilized by specialists to obtain a more in-depth evaluation of
these patients.
Although it was not the main objective of this study, we also
explored the correlations between various axis II instruments
(data not shown) and, interestingly, found that IPQ and
IEQ strongly correlated with PCS and PHQ4 (r = 0.55–0.61;
P < 0.001).
Study Limitations
Since this is a cross-sectional study, we cannot draw definite
causal conclusions regarding the relationship between pain and
well-being. The WISE pain drawing allows patients to report on
pain intensities in every region marked on the body diagram.
When a person experienced pain in multiple locations, the
limitation to a single numeric value for the typical (PI-typ)
and maximum (PI-max) pain intensity characteristic of his/her
chief complaint may have made the choice difficult. We did
not attempt to capture psychological factors that influence pain
intensity and distribution on pain drawings (79, 80), although
we are aware of their importance in understanding the somatic
awareness present in chronic pain conditions (81). Since the
DC/TMD axis II measures currently do not cover some of the
biopsychosocial aspects of interest in this study, which included
a broad variety of OFP complaints beyond TMDs, we have
incorporated several additional psychometric instruments in
our data analyses. Most patients in this study had moderate
pain intensities, which may explain why no strong correlation
levels were detected in our analyses. The low prevalence of
DCQ likely explains the lack of correlation between the DCQ
and the assessed pain dimensions. Nevertheless, the fact that
the correlation between dysmorphic concern and pain has
not previously been reported warrants further investigations.
This study did not examine the presence of additional painful
comorbidities, although patients experiencing prolonged painful
TMDs are at increased risk of suffering from other painful
conditions (82). Furthermore, we did not employ a specific
instrument for measuring well-being, such as the Warwick–
Edinburgh Mental Well-Being Scale (83). Rather, our well-being
proxy measures included the set of axis II constructs listed in the
Materials and Methods section.
CONCLUSIONS
Due to the modular structure of theWISE that questions patients
according to their symptom burden, a variable number of the
799 patients completed the axis II instruments. Pain intensities
were higher in women than men and highest in patients with
disabilities or no job. The latter group also had the highest
scores for pain-related disability, pain catastrophizing, stress,
and depression. Older patients (60+ years) had significantly
lower stress scores and were less likely to report symptoms
of anxiety or depression. When correlating pain and well-
being measures, moderate associations were observed in patients
reporting clinically relevant stress, insomnia severity, injustice
experience, and dysmorphic concern. Surprisingly, compromised
well-being in the form of anxiety, depression, and pain
catastrophizing (clinically relevant scores of GAD7, PHQ9,
and PCS) did not correlate with any of the pain measures.
The results of this study support the clinical usefulness of
the DC/TMD core assessment instruments, but also suggest
measuring of sleep, catastrophizing, injustice experience, and
dysmorphic concern as important dimensions for patients
suffering from OFP symptoms. Further studies are needed to
determine how pain and well-being influence each other, i.e., to
clarify whether there are direct causal influences or influences
mediated by other variables not investigated in this study.
Preferably this would be related to a theoretical framework about
relations between OFP, well-being, psychiatric disorders, and
socioeconomic status.
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